Hawkins, Nathaniel M.
Kaplan, Alan
Ko, Dennis T.
Penz, Erika
Bhutani, Mohit
Funding for this research was provided by:
AstraZeneca
Article History
Received: 4 July 2024
Accepted: 20 August 2024
First Online: 9 September 2024
Declarations
:
: The authors disclose the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Nathaniel M Hawkins has received grants from AstraZeneca, and consulting fees and honoraria for presentations from AstraZeneca, Bayer, and Novartis. Alan Kaplan has received consulting fees and honoraria for presentations from ALK, AstraZeneca, Belus, Eisai, GSK, Idorsia Moderna, Merck Frosst, Pfizer, Sanofi, Trudel, and Valero, and he is a board member of the Family Physicians Airways Group of Canada and the Observational and Pragmatic Research Institute Respiratory Effectiveness Group. Alan Kaplan is an Editorial Board member of <i>Pulmonary Therapy</i> and was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Dennis T Ko has no conflicts to disclose. Erika Penz has received grants from the Canadian Institute of Health Research, Saskatchewan Health Research Foundation, AstraZeneca, and Sanofi, consulting fees from AstraZeneca, GlaxoSmithKline and Sanofi, and honoraria for presentations from AstraZeneca, GlaxoSmithKline, the Canadian Thoracic Society, and COVID Pharma, support for attending meetings from GlaxoSmithKline, she participates in Data Safety Monitoring or Advisory Boards for AstraZeneca, GlaxoSmithKline, and Sanofi, and is an executive board member of the Canadian Thoracic Society, a board member of the Canadian Institute of Health Research, a medical advisor to the Lung Cancer Screening Program, and co-chair of the National Senior Respiratory Fellows Symposium. Mohit Bhutani has received grants from AstraZeneca, GSK, Sanofi, and Mereo Pharma, consulting fees and honoraria from AstraZeneca, GSK, Sanofi, Valeo and Covis, support for attending meetings from AstraZeneca, GSK, and Sanofi, and is an executive board member of the Canadian Thoracic Society.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.